MLL4 Antibodies

Santa Cruz Biotechnology provides a broad selection of MLL4 Antibodies for research focused on understanding MLL4 protein function. MLL4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MLL4, also known as KMT2D, is a histone methyltransferase that plays a critical role in gene regulation and chromatin remodeling. MLL4 is essential for normal development and has been implicated in various cancers when mutated. Understanding MLL4 function is vital for elucidating its contributions to epigenetic regulation and its potential as a therapeutic target. Research has shown that MLL4 mutations can lead to developmental disorders and contribute to cancer progression. MLL4 works in concert with other chromatin modifiers to establish and maintain specific gene expression patterns. Recent studies have highlighted MLL4's importance in cell differentiation and tissue-specific gene expression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance understanding of MLL4's role in health and disease.